T. Rowe Price Associates’s AtriCure ATRC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $1.71M | Buy |
|
|||||
|
2025
Q2 | $1.52M | Buy |
|
|||||
|
2025
Q1 | $1.4M | Sell |
|
|||||
|
2024
Q4 | $1.33M | Buy |
|
|||||
|
2024
Q3 | $1.13M | Buy |
|
|||||
|
2024
Q2 | $908K | Buy |
|
|||||
|
2024
Q1 | $980K | Sell |
|
|||||
|
2023
Q4 | $13.3M | Sell |
|
|||||
|
2023
Q3 | $19M | Sell |
|
|||||
|
2023
Q2 | $21.5M | Buy |
|
|||||
|
2023
Q1 | $18.1M | Buy |
|
|||||
|
2022
Q4 | $19.3M | Buy |
|
|||||
|
2022
Q3 | $16.9M | Sell |
|
|||||
|
2022
Q2 | $73.5M | Sell |
|
|||||
|
2022
Q1 | $124M | Sell |
|
|||||
|
2021
Q4 | $135M | Sell |
|
|||||
|
2021
Q3 | $140M | Sell |
|
|||||
|
2021
Q2 | $172M | Sell |
|
|||||
|
2021
Q1 | $148M | Sell |
|
|||||
|
2020
Q4 | $130M | Buy |
|
|||||
|
2020
Q3 | $88.5M | Sell |
|
|||||
|
2020
Q2 | $100M | Buy |
|
|||||
|
2020
Q1 | $59.6M | Sell |
|
|||||
|
2019
Q4 | $58.7M | Buy |
|
|||||
|
2019
Q3 | $45M | Buy |
|
|||||
|
2019
Q2 | $50.5M | Sell |
|
|||||
|
2019
Q1 | $58.5M | Buy |
|
|||||
|
2018
Q4 | $66.7M | Sell |
|
|||||
|
2018
Q3 | $77.6M | Sell |
|
|||||
|
2018
Q2 | $64.6M | Buy |
|
|||||
|
2018
Q1 | $30.6M | Buy |
|